NASDAQ: NTRANatera Inc Stock Ownership - Who owns Natera?
Insider buying vs selling
Have Natera Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jonathan Sheena | Director | 2025-11-21 | 2,000 | $230.01 | $460.02kSell |
| Jonathan Sheena | Director | 2025-11-21 | 2,000 | $230.01 | $460.01kSell |
| Roy D. Baynes | Director | 2025-11-20 | 900 | $221.81 | $199.63kSell |
| Roy D. Baynes | Director | 2025-11-20 | 1,800 | $222.90 | $401.22kSell |
| Roy D. Baynes | Director | 2025-11-20 | 1,184 | $220.14 | $260.65kSell |
| Roy D. Baynes | Director | 2025-11-20 | 1,900 | $223.90 | $425.42kSell |
| Roy D. Baynes | Director | 2025-11-20 | 1,884 | $224.89 | $423.69kSell |
| Roy D. Baynes | Director | 2025-11-20 | 7,068 | $41.19 | $291.13kBuy |
| Roy D. Baynes | Director | 2025-11-20 | 600 | $40.93 | $24.56kBuy |
| Jonathan Sheena | Director | 2025-11-20 | 10,000 | $225.08 | $2.25MSell |
NTRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NTRA insiders and whales buy or sell their stock.
NTRA Shareholders
What type of owners hold Natera Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.98% | 12,389,033 | $2.86B | Institution |
| Price T Rowe Associates Inc | 8.66% | 11,947,415 | $2.76B | Institution |
| Jpmorgan Chase Co | 8.43% | 11,628,914 | $2.68B | Institution |
| Blackrock Inc | 7.94% | 10,964,351 | $2.53B | Institution |
| Claremont Creek Ventures L P | 4.25% | 5,864,630 | $1.35B | Insider |
| Roelof Botha | 4.12% | 5,684,069 | $1.31B | Insider |
| Sc XII Management LLC | 3.93% | 5,421,122 | $1.25B | Insider |
| Matthew Rabinowitz | 3.48% | 4,809,420 | $1.11B | Insider |
| James Healy | 3.40% | 4,697,100 | $1.08B | Insider |
| Farallon Capital Management LLC | 3.08% | 4,253,452 | $980.97M | Institution |
NTRA vs Diagnostic & Research Stocks
Natera Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.